Lgr5DTR-eGFP tumor organoids treated with the toxin collapsed after losing their stem cells and were unable to regrow upon toxin treatment maintenance, thus demonstrating the necessity of Lgr5+ stem cells [16,50]. This evidence concerns the gene LGR5 and neoplasm.